Philip Onyebujoh

Reduced Antituberculosis Drug Concentrations in HIV-Infected Patients Who Are Men or Have Low Weight: Implications for International Dosing Guidelines

Helen McIlleron, Roxana Rustomjee, Mahnaz Vahedi et al. · Antimicrobial Agents and Chemotherapy · 2012 · 107 citations · Full text

Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective, international, randomised, placebo-controlled trial

Sayoki Mfinanga, Bruce Kirenga, Duncan Chanda et al. · The Lancet Infectious Diseases · 2014 · 96 citations

Pulmonary Tuberculosis, Treatment And Prevention, Hiv-positive Adults +6

Model-Based Evaluation of Higher Doses of Rifampin Using a Semimechanistic Model Incorporating Autoinduction and Saturation of Hepatic Extraction

Maxwell Chirehwa, Roxana Rustomjee, Thuli Mthiyane et al. · Antimicrobial Agents and Chemotherapy · 2015 · 83 citations · Full text

Immunotherapy with Mycobacterium vaccae as an addition to chemotherapy for the treatment of pulmonary tuberculosis under difficult conditions in Africa

Philip Onyebujoh, T. Abdulmumini, Sydney K. Robinson et al. · Respiratory Medicine · 1995 · 68 citations · Full text

Vaccination, Difficult Conditions, Pulmonary Tuberculosis +10

Recent bioequivalence studies on fixed-dose combination anti-tuberculosis drug formulations available on the global market.

Gopal S Pillai, P. Bernard Fourie, Nesri Padayatchi et al. · PubMed · 1999 · 52 citations